Cowden syndrome

Cancer Treatment Reviews

Volumn 36, Issue 8, 2010, Pages 577-583

  Farooq, A ^a   Walker, L J ^b   Bowling, J ^b   Audisio, R A ^a,c  

^a ST HELENS AND KNOWSLEY TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cowden disease; Cowden syndrome; PTEN

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CLINICAL FEATURE; COWDEN SYNDROME; GASTROINTESTINAL TRACT; GENETIC ANALYSIS; HUMAN; LHERMITTE DUCLOS DISEASE; REVIEW; SKELETON MALFORMATION; SKIN DEFECT; THYROID CANCER; UROGENITAL TRACT CANCER;

BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; INCIDENCE; MALE; PRECANCEROUS CONDITIONS; PROGNOSIS; PTEN PHOSPHOHYDROLASE; RISK ASSESSMENT; THYROID NEOPLASMS;

EID: 78349305785     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2010.04.002     Document Type: Review

References (91)

1. Lloyd K.M., Denis M. Cowden's disease: a possible new symptom complex with multiple system involvement. Ann Intern Med 1963, 58:136-142.
2. Weary P.E., Gorlin R.J., Gentry W.C., Comer J.E., Greer K.E. Multiple hamartoma syndrome (Cowden's disease). Arch Dermatol 1972, 106(5):682-690.
3. Nelen M.R., Padberg G.W., Peters E.A.J., Lin A.Y., van den Helm B., Frants R.R., et al. Localization of the gene for Cowden disease to 10q22-23. Nat Genet 1996, 13:114-116.
4. Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet 2000, 37:828-830.
5. Nelen M.R., Kremer H., Konings I.B.M., Schoute F., van Essen A.J., Koch R., et al. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Human Genet 1999, 7:267-273.
6. Starink T., van der Veen J., Arwert F., Eriksson A.W. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 1986, 29:222-233.
7. Salem O.S., Steck W.D. Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. J Am Acad Dermatol 1983, 8(5):686-696.
8. The NCCN 1.2009 Cowden syndrome clinical practice guidelines in oncology. National Comprehensive Cancer Network, 2009. Available from: Adapted with permission from NCCN [accessed 10.06.09]. (To view the most recent and complete version of the guideline, go online to ). http://www.nccn.org.
9. Fistarol S.K., Marc D., Anliker M.D., Peter H. Cowden disease or multiple hamartoma syndrome - cutaneous clue to internal malignancy. Eur J Dermatol 2002, 12(5):411-421.
10. Starink T.M., Hausman R. The cutaneous pathology of facial lesions in Cowden's disease. J Cutan Pathol 1984, 11:331-337.
11. Kovich O., Cohen D. Cowden's syndrome. Dermatol Online J 2004, 10(3):3.
12. Giannada E. Maladie de Cowden ou syndrome des hamartomes multiples: revue generale a propos d'un cas; thesis, Department of Dermatology, University of Lausanne, 1980, p. 1-196.
13. Brownstein M.H., Mehregan A.H., Bilowski J.B. Trichilemmomas in Cowden's disease. J Am Med Assoc 1977, 238(1):26.
14. Jornayvaz F.R., Philippe J. Mucocutaneous papillomatous papules in Cowden's syndrome. Clin Exp Dermatol 2008, 33(2):151-153.
15. Botma M., Russell D.I., Kell R.A. Cowden's disease: a rare cause of oral papillomatosis. J Laryngol Otol 2002, 116(3):221-223.
16. Devlin M.F., Barrie R., Ward-Booth R.P. Cowden's disease: a rare but important manifestation of oral papillomatosis. Brit J Oral Maxillofac Surg 1992, 30:335-336.
17. Brownstein M.H., Mehregan A.H., Bikowski J.B., Lupulescu A., Patterson J.C. The dermatopathology of Cowden's syndrome. Brit J Dermatol 1979, 100(6):667-673.
18. Blumenthal G.M., Dennis P.A. PTEN hamartoma tumor syndromes. Eur J Human Genet 2008, 16:1289-1300.
19. Cañadas L.M.C., Sánchez S.J.L., Castillo S.L.M., Moleón I.L.L., Moreno D.D., López D.S., et al. Multiple oral fibropapillomatosis as an initial manifestation of Cowden syndrome. Case report. Medicina Oral, Patologica Oral y Cirugia Bucal 2006, 11:E319-24.
20. Mignogna M.D., Lo Muzio L., Ruocco V., Bucci E. Early diagnosis of multiple hamartoma and neoplasia syndrome (Cowden disease). The role of the dentist. Oral Surg, Oral Med, Oral Pathol, Oral Radiol, Endodont 1995, 79(3):295-299.
21. Smid L., Zargi M. Cowden's disease - its importance for otolaryngologists. J Laryngol Otol 1993, 107:1063-1065.
22. Barax C.N., Lebwohl M., Phelps R.G. Multiple hamartoma syndrome. J Am Acad Dermatol 1987, 17(2):342-346.
23. Wade T.R., Kopf A.W. Cowden's disease: a case report and review of the literature. J Dermatol Surg Oncol 1978, 4:459-464.
24. Koeppel M.C., Lazzarini F., Lagrange B., Sayag J. Cowden's disease. Adenomatous polyps. Periorifichal lentiginosis. Annales de Dermatologie et Venereologie 1990, 117:455-458.
25. Schaffer J.V., Kamino H., Witkiewicz A., McNiff J.M., Orlow S.J. Mucocutaneous neuromas: an under-recognized manifestation of PTEN hamartoma-tumor syndrome. Arch Dermatol 2006, 142(5):625-632.
26. Ferran M., Bussalgia E., Lazaro C., Matias-Guiu X., Pujol R.M. Acral papular neuromatosis: an early manifestation of Cowden syndrome. Brit J Dermatol 2008, 158:174-176.
27. Tsou H.C., Teng D.H., Ping X.L., Brancolini V., Davis T., Hu R. The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases. Am J Human Genet 1997, 61(5):1036-1043.
28. Lynch E.D., Ostermeyer E.A., Lee M.K., Arena J.F., Ji H., Dann J. Inherited mutations in PTEN that are associated with breast cancer, Cowden syndrome and juvenile polyposis. Am J Human Genet 1997, 61:1254-1260.
29. Nusbaum R., Vogel J.K., Ready K. Susceptibility to breast cancer: hereditary syndromes and low penetrance genes. Breast Dis 2007, 27:21-50.
30. Brownstein M.H., Wolf M., Bikowski J.B. Cowden's disease: a cutaneous marker of breast cancer. Cancer 1978, 41:2393-2398.
31. Schrager C.A., Schneider D., Gruener A.C. Clinical and pathological features of breast disease in Cowden's syndrome: an under-recognized syndrome with an increased risk of breast cancer. Human Pathol 1998, 29:47-53.
32. Eng C., Robinson B.G. Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet 2001, 38(3):159-164.
33. Fackenthal J.D., Marsh D.J., Richardson A.L., Cummings S.A., Eng C., Robinson B.G., et al. Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet 2001, 38:159-164.
34. Harach H.R., Soubeyran I., Brown A., Bonneau D., Longy M. Thyroid pathologic findings in patients with Cowden disease. Ann Diagn Pathol 1999, 3(6):331-340.
35. Koksal Y., Sahin M., Koksal H., Orhan D., Unal E., Alagoz E. Thyroid medullary carcinoma in a teenager with Cowden Syndrome. Laryngoscope 2007, 117:1180-1182.
36. Tan W.H., Baris H.N., Burrows P.E., Robson C.D., Alomari A.I., Mulliken J.B. The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet 2007, 44(9):594-602.
37. Woodhouse J., Ferguson M.M. Multiple hyperechoic testicular lesions are a common finding on ultrasound in Cowden disease and represent lipomatosis of the testis. Brit J Radiol 2006, 79(946):801-803.
38. Lindsay C., Boardman L., Farrell M. Testicular hamartomas in Cowden disease. J Clin Ultrasound 2003, 31(9):481-483.
39. Mazereeuw-Hautier J., Assouere M.N., Moreau-Cabarrot A., Longy M., Bonafe J.L. Cowden's syndrome: possible association with testicular seminoma. Brit J Dermatol 2004, 150(2):378-379.
40. Devi M., Leonard N., Silverman S., Al-Qahtani M., Girgis R. Testicular mixed germ cell tumor in an adolescent with Cowden disease. Oncology 2007, 72(3-4):194-196.
41. Mutter G.L., Lin M.C., Fitzgerald J.T., Kum J.B., Baak J.P., Lees J.A. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J National Cancer Institute 2000, 92(11):924-930.
42. Blumenthal G.M., Dennis P.A. Germline PTEN mutations as a cause of early-onset endometrial cancer. J Clin Oncol 2008, 26(13):2234.
43. Allen B.S., Fitch M.H., Smith J.G. Multiple hamartoma syndrome. A report of a new case with associated carcinoma of the uterine cervix and angioid streaks of the eyes. J Am Acad Dermatol 1980, 2:303-308.
44. Aylesworth R., Vance J.C. Multiple hamartoma syndrome with endometrial carcinoma and the sign of Leser-Trelat. Arch Dermatol 1982, 118:136-138.
45. Haibach H., Burns T.W., Carlson H.E., Burman K.D., Deftos L.J. Multiple hamartoma syndrome (Cowden's disease) associated with renal cell carcinoma and primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Am J Clin Pathol 1992, 97(5):705-712.
46. Carlson G.J., Nivatvongs S., Snover D.C. Colorectal polyps in Cowden's disease (multiple hamartoma syndrome). Am J Surg Pathol 1984, 8(10):763-770.
47. Taylor A.J., Dodds W.J., Stewart E.T. Alimentary tract lesions in Cowden's disease. Brit J Radiol 1989, 62(742):890-892.
48. Olschwang S., Serova-Sinilnikova O.M., Lenoir G.M., Thomas G. PTEN germ-line mutations in juvenile polyposis coli. Nat Genet 1998, 18(1):12-14.
49. Kay P.S., Soetikno R.M., Mindelzun R., Young H.S. Diffuse esophageal glycogenic acanthosis: an endoscopic marker of Cowden's disease. Am J Gastroenterol 1997, 92(6):1038-1040.
50. McGarrity T.J., Baker M.J., Ruggiero F.M., Thiboutot D.M., Hampel H., Zhou X.P. GI polyposis and glycogenic acanthosis of the esophagus associated with PTEN mutation positive Cowden syndrome in the absence of cutaneous manifestations. Am J Gastroenterol 2003, 98(6):1429-1434.
51. Robinson S., Cohen A.R. Cowden disease and Lhermitte-Duclos disease: Aan update. Case report and review of the literature. Neurosurg Focus 2006, 20(1).
52. Padberg G.W., Schot J.D.L., Vielvoye G.J., Bots G.T.A.M., de Beer F.C. Lhermitte-Duclos disease and Cowden syndrome: a single phakomatosis. Ann Neurol 1991, 29:517-523.
53. Hanssen A.M., Werquin H., Suys E. Cowden syndrome: report of a large family with macrocephaly and increased severity of signs in subsequent generations. Clin Genet 1993, 44:281-286.
54. Parisi M., Dinulos M.B., Leppid K.A., Sybert V.P., Eng C., Hudgins L. The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome. J Med Genet 2001, 38:52-57.
55. Lok C., Viseux V., Avril M.F., Richard M.A., Gondry-Jouet C., Deramond H., et al. Brain magnetic resonance imaging in patients with Cowden syndrome. Medicine (Baltimore) 2005, 84(2):129-136.
56. Scheper M.A., Nikitakis N.G., Sarlani E., Sauk J.J., Meiller T.F. Cowden syndrome: report of a case with immunohistochemical analysis and review of the literature. Oral Surg, Oral Med, Oral Pathol, Oral Radiol Endodentol 2006, 101(5):625-631.
57. Li D.M., Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997, 57(11):2124-2129.
58. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K.A., Lin H., Ligon A.H., et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997, 25:356-362.
59. Pilarski R., Eng C. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 2004, 41(5):323-326.
60. Huang J., Kontos C.D. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem 2002, 277(13):10760-10766.
61. Lopiccolo J., Ballas M.S., Dennis P.A. PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug development. Crit Rev Oncol/Hematol 2007, 63:203-214.
62. Waite K.A., Eng C. Protean PTEN: form and function. Am J Human Genet 2002, 70(4):829-844.
63. Greene S.L., Thomas J.R., Doyle J.A. Cowden's disease with associated malignant melanoma. Int J Dermatol 1984, 23(7):466-467.
64. Li D.M., Sun H. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc National Acad Sci 1998, 95(26):15406-15411.
65. Li Y., Guessous F., DiPierro C., et al. Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy. Molec Cancer Therapeut 2009, 8(2):376-385.
66. Mutter G.L., Lin M.C., Fitzgerald J.T., Kum J.B., Baak J.P., Lees J.A. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J National Cancer Inst 2000, 92(11):924-930.
67. Guigon C.J., Zhao L., Willingham M.C., Cheng S.Y. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer. Oncogene 2009, 28(4):509-517.
68. Guldberg P., thor Straten P., Birck A., Ahrenkiel V., Kirkin A.F., Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 1997, 57(17):3660-3663.
69. Koul D., Shen R., Garyali A., Ke L.D., Liu T.J., Yung W.K. MMAC/PTEN tumor suppressor gene regulates vascular Cowden Syndrome: a critical review of the clinical literature 25 endothelial growth factor-mediated angiogenesis in prostate cancer. Int J Oncol 2002, 21(3):469-475.
70. Bansal N., Yendluri V., Wenham R.M. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control 2009, 16(1):8-13.
71. Liaw D., Marsh D.J., Li J., Dahia P.L.M., Wang S.I., Zheng Z. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997, 16:64-67.
72. Tate G., Suzuki T., Endo Y., Mitsuya T. A novel mutation of the PTEN gene in a Japanese patient with Cowden syndrome and bilateral breast cancer. Cancer Genet Cytogenet 2008, 184(1):67-71.
73. Zhou X.P., Waite K.A., Pilarski R., Hampel H., Fernandez M., Bos C., et al. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Human Genet 2003, 73(2):404-411.
74. Reifenberger J., Rauch L., Beckmann M.W., Megahed M., Ruzicka T., Reifenberger G. Cowden's disease: clinical and molecular genetic findings in a patient with a novel PTEN germline mutation. Brit J Dermatol 2003, 148(5):1040-1046.
75. Marsh D.J., Coulon V., Lunetta K.L., Rocca-Serra P., Dahia P.L., Zheng Z., et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Human Molec Genet 1998, 7:507-515.
76. De Vivo I., Gertig D.M., Nagase S., Hankinson S.E., O'Brien R., Speizer F.E. Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers. J Med Genet 2000, 37(5):336-341.
77. Teresi R.E., Zbuk K.M., Pezzolesi M.G., Waite K.A., Eng C. Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation. Am J Human Genet 2007, 81(4):756-767.
78. Biesecker L.G., Happle R., Mulliken J.B., Weksberg R., Graham J.M., Viljoen D.L. Proteus syndrome: diagnostic criteria, differential diagnosis and patient evaluation. Am J Med Genet 1999, 84:389-395.
79. Zhuk K.M., Eng C. Cancer phenomics: RET and PTEN as illustrative models. Nat Rev Cancer 2007, 7:35-45.
80. Eng C. PTEN: one gene, many syndromes. Human Mutat 2003, 22:183-198.
81. Gorlin R.J., Cohen M.M., Condon L.M., Burke B.A. Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 1992, 44(3):307-314.
82. Lachlan K.L., Lucassen A.M., Bunyan D., Temple I.K. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 2007, 44(9):579-585.
83. Pezzolesi M.G., Platzer P., Waite K., Eng C. Differential expression of PTEN-targeting MicroRNAs miR-19a and miR-21 in Cowden syndrome. Am J Human Genet 2008, 82:1141-1149.
84. Hino R., Uozaki H., Murakami N., Ushiku T., Shinozaki A., Ishikawa S., et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 2009, 69(7):2766-2774.
85. Ni Y., Zbuk T., Sadler, Patocs A., Lobo E., Edelman E., et al. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Human Genet 2008, 83:261-268.
86. Gustafson S., Zbuk K.M., Scacheri C., Eng C. Cowden syndrome. Semi Oncol 2007, 34:428-434.
87. Hartmann L.C., Schaid D.J., Woods J.E. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New Engl J Med 1999, 340:77-84.
88. Thull D.L., Vogel V.G. Recognition and management of hereditary breast cancer syndromes. Oncologist 2004, 9:13-24.
89. Wheeland R.G., McGillis S.T. Cowden's disease - treatment of cutaneous lesions using carbon dioxide laser vaporization: a comparison of conventional and superpulsed techniques. J Dermatol Surg Oncol 1989, 15:1055-1059.
90. Obara S., Nakata M., Takeshima H., Katagiri H., Asano T., Oka Y., et al. Integrin-linked kinase (ILK) regulation of the cell viability in PTEN mutant glioblastoma and in vitro inhibition by the specific COX-2 inhibitor NS-398. Cancer Lett 2004, 208(1):115-122.
91. Squarize C.H., Castilho R.M., Gutkind J.S. Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin. Cancer Res 2008, 68(17):7066-7072.